exRNAdisease

Entry Detail

---



General Information

Database ID: exR0261877 RNA Name: hsa-miR-217-5p RNA Type: miRNA Chromosome: chr2 Starnd: - Coordinate: Start Site(bp): 55983020 End Site(bp): 55983042 External Links: hsa-miR-217-5p

Disease Information

Disease Name: Prostate Cancer Disease Category: Cancers MeSH ID: D011471 Type: Neoplasms/Digestive System Neoplasms Alias: Prostatic Neoplasms//Prostate Neoplasms//Neoplasms, Prostate//Neoplasm, Prostate//Prostate Neoplasm//Neoplasms, Prostatic//Neoplasm, Prostatic//Prostatic Neoplasm//Prostate Cancer//Cancer, Prostate//Cancers, Prostate//Prostate Cancers//Cancer of the Prostate//Prostatic Cancer//Cancer, Prostatic//Cancers, Prostatic//Prostatic Cancers//Cancer of Prostate

Expression Detail

GEO ID: GSE134266 Description: Deep sequencing identified serum extracellular vesicle delivered miR-181a-5p as an indicator for bone-metastatic prostate cancer (microarray) Experimental Design: Cancer vs Control Case Disease Type: Prostate Cancer Case Disease SubType: Bone Metastatic Prostate Cancer Case Sample: Bone Metastatic Prostate Cancer Control Sample: Benign Prostatic Hyperplasia Number of Case: 8 Number of Control: 9 Number of Samples: 17

Regulatory Relationship

mRNA targets: Gene Symbol Chromosome Start Site(bp) End Site(bp) Strand PNPO chr17 47941506 47949308 + SLC26A2 chr5 149960758 149993455 + ICAM1 chr19 10271093 10286615 + ARHGAP11A chr15 32615144 32639941 + SFXN1 chr5 175477062 175529742 + EIF1AD chr11 65996545 66002176 - KPNA4 chr3 160495007 160565571 - LYSMD4 chr15 99715697 99733561 - AXL chr19 41219223 41261766 + OPA3 chr19 45527427 45602212 - IRF4 chr6 391752 411443 + SLC25A32 chr8 103398635 103415189 - UBE2G1 chr17 4269259 4366628 - MMD chr17 55392622 55421924 - CDH1 chr16 68737292 68835541 + ICK chr6 53001279 53061802 - PARD6B chr20 50731580 50756795 + GOLGA3 chr12 132768914 132829078 - MET chr7 116672196 116798386 + ACER2 chr9 19409009 19452505 + PSKH1 chr16 67893254 67929676 + EIF2S3 chrX 24054946 24078810 + VHL chr3 10141008 10152220 + DDX3X chrX 41333284 41364472 + ZNF587 chr19 57849859 57865117 + TSEN54 chr17 75516060 75524735 + CNN2 chr19 1026586 1039068 + CHD9 chr16 53055033 53329150 + ERLIN1 chr10 100150094 100186033 - TFPI chr2 187464230 187565760 - miRNA targets: NA circRNA targets: NA lncRNA targets: lncRNA Symbol Chromosome Start Site(bp) End Site(bp) Strand ADAMTSL4-AS1 chr1 150560202 150574552 - AP000553.1 chr22 21652270 21670237 + GAS5 chr1 173858559 173868882 - LINC01578 chr15 92819540 92899701 + MALAT1 chr11 65497688 65506516 + NEAT1 chr11 65422774 65445540 + OIP5-AS1 chr15 41283990 41309737 + XIST chrX 73820649 73852723 - Display:

Experiment Detail

GEO ID: GSE134266 Sample Source: Blood Source Fraction: Extracellular Vesicle Platform: GPL25134 Method: Microarray Num of detected RNA Type: 1 Num of detected RNAs of this Type: 2519 Sample treatment protocol: The blood was centrifuged at 2000 g for 10 min at 4 °C to extract the serum. The serum EV was extracted using Total Exosome Isolation Kit (from serum, Thermo fisher scientific). RNA Extract protocol: Exosome Purification and RNA Isolation Kit (Norgen Biotek) was employed to purify EV and extract total RNA in EV consequentially. RNA library preparation protocol: Sample tag and reagents are included in the hybrid need Agilent's micrornas Complete Labeling and Hyb Kit (p/n 5190-0456).

Reference

PMID: NA Title: NA Author: NA Journal: NA Description: NA